Evidence map›Paper›PMID 21752283›Full record

ArticleMolecular cancer2011

Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis.

Yanfang Wang, Sylvia Shenouda, Somesh Baranwal, Rajamani Rathinam, Prachi Jain, Lili Bao, Siddhartha Hazari, Srikanta Dash, Suresh K Alahari

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Integrin αBiomaterials · 2018
    Article
  13. Facile metabolic glycan labeling strategy for exosome tracking.Biochimica et biophysica acta. General subjects · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yanfang WangDepartment of Biochemistry and Molecular Biology, Stanley Scott Cancer Center, LSU Health Sciences Center, New Orleans, LA 70112, USA.
Sylvia Shenouda
Somesh Baranwal
Rajamani Rathinam
Prachi Jain
Lili Bao
Siddhartha Hazari
Srikanta Dash
Suresh K Alahari
Louisiana State University Health Sciences Center New Orleans · USTulane University · US

Funding

Hepatocarcinogenesis Secondary to Hepatitis CR01CA127481 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI DASH, SRIKANTA · 2008 to 2012
$1.4M
A Novel Regulator of Cancer Cell Migration and InvasionR01CA115706 · NCI · LSU HEALTH SCIENCES CENTER · PI ALAHARI, SURESH K. · 2006 to 2010
$1.0M
Intracellular immunization strategy in inhibit HCV related liver cancerR21CA129776 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI DASH, SRIKANTA · 2009 to 2010
$343k
NCI NIH HHS 5R01CA115706NCI NIH HHS CA127481NCI NIH HHS CA129776
6 · The paper itself

Abstract

backgroundAlthough integrins have been implicated in the progression of breast cancer, the exact mechanism whereby they exert this regulation is clearly not understood. To understand the role of integrins in breast cancer, we examined the expression levels of several integrins in mouse breast cancer cell lines by flow cytometry and the data were validated by Western and RT-PCR analysis. The importance of integrins in cell migration and cell invasion was examined by in vitro assays. Further the effect of integrins on metastasis was investigated by in vivo experimental metastasis assays using mouse models.

resultsIntegrin α5 subunit is highly expressed in the nonmetastatic cell line 67NR and is significantly low in the highly invasive cell line 4T1. In contrast, expression levels of integrin α6 subunit are high in 4T1 cells and low in 67NR cells. In vitro data indicated that overexpression of α5 subunit and knockdown of α6 integrin subunit inhibited cell proliferation, migration, and invasion. Our in vivo findings indicated that overexpression of integrin α5 subunit and knockdown of α6 subunit decreased the pulmonary metastasis property of 4T1 cells. Our data also indicated that overexpression of alpha 5 integrin subunit and suppression of alpha6 integrin subunit inhibited cells entering into S phase by up-regulating p27, which results in downregulation of cyclinE/CDK2 complexes, This suggests that these integrins regulate cell growth through their effects on cell-cycle-regulated proteins. We also found that modulation of these integrins upregulates E2F, which may induce the expression of chk1 to regulate cdc25A/cyclin E/CDK2/Rb in a feedback loop mechanism.

conclusionThis study indicates that Integrin α5 subunit functions as a potential metastasis suppressor, while α6 subunit functions as a metastasis promoter. The modulation of integrins reduces cdc25 A, another possible mechanism for downregulation of CDK2. Taken together we demonstrate a link between integrins and the chk1-cdc25-cyclin E/CDK2-Rb pathway.

Indexed as

AnimalsBreast NeoplasmsCarcinomaCell CycleCell Line, TumorCheckpoint Kinase 1E2F Transcription FactorsFemaleGene Expression Regulation, NeoplasticIntegrin alpha5Integrin alpha6MiceMice, NudeNeoplasm MetastasisProtein KinasesProtein SubunitsCheckpoint Kinase 1Chek1 protein, mouseE2F Transcription FactorsIntegrin alpha5Integrin alpha6Protein KinasesProtein SubunitsRetinoblastoma Protein

Identifiers

PMID21752283
PMCPMC3163626
OpenAlexW2128178837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.